Shares of Boston Scientific (BSX) lost ~10% in the morning hours on Wednesday to hit a 52-week low after the MedTech highlighted an ongoing slowdown in demand for its WATCHMAN cardiac implant.
With its Q1 2026 results in April, Boston Scientific ( Shares of Boston Scientific (BSX) lost ~10% in the morning hours on Wednesday to hit a 52-week low after the MedTech highlighted an ongoing slowdown in demand for its WATCHMAN cardiac implant
With its Q1 2026 results in April, Boston Scientific (